We are L-Citrulline CAS:372-75-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
L-Citrulline
Converted to L-arginine and enhance production of nitric oxide (NO). It is reported that L-citrulline NO bioavailability is superior to that of L-arginine. Widely used in sports nutrient.
| Cas.No | 372-75-8 |
| Assay | 99.0 – 101.0% |
| Specification | White crystals or crystalline powder |
| Applications | Sport Nutrition, NO booster, Men's health, Dietary Supplement |
| Packaging | 25kg |
SPECIFICATION AND PROCEDURE
| APPEARANCE | White crystalline powder |
| IDENTIFICATION | CONFORMS |
| pH | 5.7 – 6.7 |
| SPECIFIC ROTATION (AT 20°C) | +24.5 to +26.5 |
| AMMONIUM | Not More Than 0.020% |
| CHLORIDE | Not More Than 0.017% |
| SULFATE | Not More Than 0.020% |
| IRON | Not More Than 10 PPM |
| HEAVY METALS | Not More Than 10 PPM |
| LEAD | Not More Than 10 PPM |
| ARSENIC | Not More Than 1 PPM |
| FOREIGN AMINO ACIDS | Not More Than 0.5% |
| LOSS ON DRYING | Not More Than 0.20% |
| RESIDUE ON IGNITION | Not More Than 0.10% |
| ASSAY (DRIED BASIS) | 99.0 – 101.0% |
| TOTAL COUNT (CFU) | Not More Than 1,000/g |
| YEASTS AND MOLDS (CFU) | Not More Than 100/g |
| COLIFORM | NEG |
Related News: In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.2-fluoro-5-metilanilina CAS:452-84-6 In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.9-bromo-10-(2-biphenyl)anthracene In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.1-(3-methoxypropyl)piperidin-4-one CAS:16771-85-0 The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion.The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion.
| Product Name | |
|---|---|
| Ethylene methacrylate Cas:97-90-5 | View Details |
| [(2S,5R)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methyl benzoate | View Details |
| d( )-malic acid Cas:636-61-3 | View Details |